Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Sale of 12,500 BLCO shares, $206.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Bausch & Lomb Corp (BLCO) | Sale | 12,500 | $206.3K |
| May 28, 2026 | Bausch & Lomb Corp (BLCO) | Grant/Award | 15,842 | $250.0K |
| Mar 3, 2026 | Bausch & Lomb Corp (BLCO) | Purchase | 4,364 | $79.9K |
| May 28, 2025 | Bausch & Lomb Corp (BLCO) | Grant/Award | 20,338 | n/a |
| May 6, 2025 | Bausch & Lomb Corp (BLCO) | Purchase | 1,695 | $19.9K |
| Aug 22, 2024 | TriSalus Life Sciences, Inc. (TLSI) | Grant/Award | 15,000 | n/a |
| Aug 6, 2024 | Bausch & Lomb Corp (BLCO) | Grant/Award | 14,696 | n/a |
| Jun 5, 2024 | TriSalus Life Sciences, Inc. (TLSI) | Gift | 35,000 | n/a |
| Aug 14, 2023 | TriSalus Life Sciences, Inc. (TLSI) | Grant/Award | 35,000 | n/a |
| Jun 17, 2023 | Celularity Inc (CELU) | Grant/Award | 199,921 | n/a |